Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity (Q57905183)

From Wikidata

Jump to navigation Jump to search

article

Language	Label	Description	Also known as
English	Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: Risk factors for early regimen-related toxicity	article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for marrow transplantation: risk factors for early regimen-related toxicity (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

author name string

D Przepiorka

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

T Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

C Ippoliti

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

K Diener

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

M Luna

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 April 1994

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

68

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

183-188

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiotepa, busulfan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse alveolar hemorrhage in autologous bone marrow transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving busulfan/cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity of a busulfan-cyclophosphamide conditioning regimen in 70 patients undergoing allogeneic bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Critical issues in bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allogeneic bone marrow transplantation in high-risk myeloid disorders using busulfan, cytosine arabinoside and cyclophosphamide (BAC).

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Venoocclusive disease of the liver following bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved results of allogeneic bone marrow transplantation for advanced hematologic malignancy using busulfan, cyclophosphamide and etoposide as cytoreductive and immunosuppressive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/8003559

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF01834364

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8003559%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57905183&oldid=1809610638"